Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging in Two Years

NCT02041117 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT02041117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02041117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resuvastatin Treatment for Symptomatic Middle Cerebral Artery Stenosis Based on High-resolution Magnetic Resonance Imaging in Two Years
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 24, 2014
Completion date
November 6, 2018
Enrollment
162 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial arterial stenosis